Literature DB >> 6610834

Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.

T Kamata, J R Feramisco.   

Abstract

Several human tumour cell lines contain genes that can transform NIH 3T3 cells into malignant cells. Certain genes have been classified as members of the ras oncogene family, namely, Ha-ras, Ki-ras or N-ras. The proteins encoded by the ras family are generally small (Ha-ras, for example, encodes a protein of molecular weight 21,000 named p21), and are associated with the inner surface of the plasma membrane. The only known biochemical property common to all forms of the ras proteins is the ability to bind guanine nucleotides, a property which may be closely related to the transforming ability of ras proteins. A GTP-dependent, apparent autophosphorylation (on threonine 59) activity has been identified only in the case of the v-Ha-ras protein. Although the role of these biochemical activities in the transformation process remains unclear, we have initiated studies to determine the possible biochemical interactions of ras proteins with other membrane components. We report here the evidence that epidermal growth factor enhances the guanine nucleotide binding activity of activated c-Ha-ras or v-Ha-ras p21, and phosphorylation of v-Ha-ras p21, suggesting that some mitogenic growth factors may regulate those activities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610834     DOI: 10.1038/310147a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  44 in total

1.  Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis.

Authors:  E Ierardi; M Principi; R Francavilla; S Passaro; F Noviello; O Burattini; A Francavilla
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  Modulation of maturation and ribosomal protein S6 phosphorylation in Xenopus oocytes by microinjection of oncogenic ras protein and protein kinase C.

Authors:  T Kamata; H F Kung
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

Review 3.  The quest to overcome resistance to EGFR-targeted therapies in cancer.

Authors:  Curtis R Chong; Pasi A Jänne
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

4.  Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

Authors:  Young Hwa Soung; Jong Woo Lee; Su Young Kim; Si Hyung Seo; Won Sang Park; Suk Woo Nam; Sang Yong Song; Joung Ho Han; Cheol Keun Park; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Virchows Arch       Date:  2005-04-07       Impact factor: 4.064

5.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

Review 6.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

7.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr-25000 protein in rat liver plasma membranes.

Authors:  C M Heyworth; A D Whetton; S Wong; B R Martin; M D Houslay
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

Review 9.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

10.  Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor.

Authors:  I A McKay; P Malone; C J Marshall; A Hall
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.